Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

License agreement with Cavium

17 Jun 2013 07:00

RNS Number : 1285H
Imagination Technologies Group PLC
17 June 2013
 



17 June 2013

 

Imagination Technologies

 

Imagination signs license agreement with Cavium for Imagination's latest MIPSr5 architecture

 

Imagination Technologies (LSE: IMG.L), a leading multimedia, processor, communications and cloud technologies company, has signed a license agreement with Cavium, Inc. for the latest Release 5 MIPS architecture (MIPSr5).

 

Cavium will feature the MIPSr5 technologies, including hardware virtualization, in all members of its ultra-high-performance 1 - 48 core OCTEON® III family of products.

 

Under the terms of its licensing arrangements, Imagination receives license fees and royalty revenues on shipment of SoCs incorporating Imagination's IP.

 

 

Enquiries

 

Imagination Technologies Group plc

Tel : 01923 260 511

Sir Hossein Yassaie, CEO

Richard Smith, CFO

College Hill

Tel: 020 7457 2020

Adrian Duffield / Kay Larsen

 

 

About Imagination Technologies

Imagination Technologies - a global leader in multimedia, processor, communication and cloud technologies - creates and licenses market-leading processor solutions including graphics, video, vision, CPU and embedded processing, multi-standard communications, cross-platform V.VoIP and VoLTE, and cloud connectivity. These silicon and software intellectual property (IP) solutions for systems-on-chip (SoC) are complemented by an extensive portfolio of software, tools and ecosystems. Target markets include mobile phone, connected home consumer, mobile and tablet computing, in-car electronics, networking, telecoms, health, smart energy and connected sensors. Imagination's licensees include many of the world's leading semiconductor manufacturers, network operators and OEM/ODMs. Corporate headquarters are located in the United Kingdom, with sales and R&D offices worldwide. See: www.imgtec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKKLFAADEFF

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS